Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-α2b and folinic acid. The “GISCAD” experience

Advanced Colorectal Cancer Meta-analysis Project, 1992, Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer. Evidence in terms of response rate, J Clin Oncol, 10, 896, 10.1200/JCO.1992.10.6.896 Labianca, 1991, Folinic acid + 5fluorouracil (5FU) versus equidose 5FU in advanced colorectal cancer. Phase III study of GISCAD (Italian Group for the Study of Digestive Tract Cancer), Ann Oncol, 2, 673, 10.1093/oxfordjournals.annonc.a058047 Brouty-Boye, 1989, Inhibition by interferon of thymidine uptake in chemostat cultures of L 1210 cells, Intervirology, 9, 243, 10.1159/000148942 Lindley, 1990, Interferon-alpha increases 5-fluorouracil (5FU) plasma levels 16-fold within 1 hour. Results of a phase I study, J Interferon Res, 10, 5 Chu, 1990, Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line, Cancer Res, 50, 5834 Wadler, 1990, Clinical update on the role of fluorouracil and recombinant interferon alpha-2a in the treatment of colorectal carcinoma, Semin Oncol, 17, 16 Wadler, 1989, The clinical utility of combinations of alpha-interferon and 5-fluorouracil in the treatment of advanced large bowel cancer, 10 Elias, 1988, Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative response and synergistic interactions with halogenated pyrimidine antimetabolites, Cancer Res, 48, 4868 Miller, 1981, Reporting results on cancer treatment, Cancer, 47, 207, 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6 Simon, 1989, Optimal two-stage design for phase II clinical trials, Controlled Clin Trials, 10, 1, 10.1016/0197-2456(89)90015-9 Kaplan, 1985, Non-parametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Kemeny, 1990, Interferon alpha-2a and 5fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity, Cancer, 66, 2470, 10.1002/1097-0142(19901215)66:12<2470::AID-CNCR2820661205>3.0.CO;2-Y Pazdur, 1990, Phase II study of fluorouracil and recombinant interferon alpha-2a in previously untreated advanced colorectal carcinoma, J Clin Oncol, 8, 2027, 10.1200/JCO.1990.8.12.2027 Wadler, 1991, Phase II trial of fluorouracil and recombinant interferon alpha-2a in patients with advanced colorectal carcinoma. An Eastern Cooperative Oncology Group study, J Clin Oncol, 9, 1806, 10.1200/JCO.1991.9.10.1806 York, 1993, A randomized phase III trial comparing 5FU with or without Interferon alpha 2a for advanced colorectal cancer, 12, 590 Kocha, 1993, 5-fluorouracil plus leucovorin (LV) in metastatic colorectal cancer. Results of a multicentric multinational phase III study, Proc ASCO, 12, 562 Houghton, 1993, Interferon, leucovorin and 5fluorouracil combinations in colon carcinoma. Fourth International Congress on Anti-Cancer Chemotherapy, 159 Sinnige, 1992, In vitro and clinical modulation of 5fluorouracil with leucovorin and/or alpha-2a Interferon in colorectal cancer, 11, 464 Grem, 1991, A pilot study of interferon alpha-2a in combination with 5fluorouracil plus high dose leucovorin in metastatic gastrointestinal carcinoma, J Clin Oncol, 9, 1811, 10.1200/JCO.1991.9.10.1811 Grem, 1993, A phase II study of interferon alpha 2a (IFN) in combination with 5-fluorouracil (5FU) and leucovorin in advanced colorectal cancer, 12, 600 Cascinu, 1992, Double biochemical modulation of 5fluorouracil by leucovorin and cyclic low dose interferon alpha-2b in advanced colorectal cancer patients, Ann Oncol, 3, 489, 10.1093/oxfordjournals.annonc.a058244 Quan, 1991, Phase I trial of ALF: alpha interferon, leucovorin and 5fluorouracil in advanced colon cancer, 10, 153 Schmoll, 1992, Interferon alpha-2b, 5fluorouracil and folinic acid combination therapy in advanced colorectal cancer: preliminary results of phase I–II trial, Semin Oncol, 19, 191 Yalavarthi, 1990, Phase I/II trial of 5FU, leucovorin and rHuIFN alpha-2a in metastatic colorectal cancer: possible decrease in myelosuppression, 9, 487 Piedbois, 1991, 5FU, folinic acid and alpha-2a interferon combination in advanced gastrointestinal cancer, 10, 430 Taylor, 1991, Combination therapy with 5fluorouracil, leucovorin and interferon alpha in patients with adenocarcinoma, 10, 432 Inoshita, 1991, Phase I trial of 5FU, leucovorin, and rHuIFN alpha-2a in metastatic colorectal cancer, 10, 475 Punt, 1991, A phase I/II study of high-dose 5fluorouracil, leucovorin and interferon in patients with advanced colorectal cancer, 10, 465 Seymour, 1991, 5fluorouracil, leucovorin and alpha-interferon: a new regimen suitable for randomized trials, 10, 507 Sobrero, 1992, Phase II study of 5fluorouracil plus leucovorin and interferon alpha-2b in advanced colorectal cancer, Eur J Cancer, 28A, 850, 10.1016/0959-8049(92)90130-T Kreuser, 1991, Double modulation of 5fluorouracil with interferon alpha-2b and folinic acid in metastatic colorectal cancer, 10, 468 Bukowski, 1992, A phase I trial of 5fluorouracil, folinic acid and alpha-2a interferon in patients with metastatic colorectal carcinoma, Cancer, 69, 889, 10.1002/1097-0142(19920215)69:4<889::AID-CNCR2820690409>3.0.CO;2-R Lembersky, 1992, Phase II trial of 5-fluorouracil, leucovorin and interferon alpha-2b in the treatment of metastatic colorectal cancer, 11, 559 Moore, 1992, A phase II clinical and pharmacologic study of 5fluorouracil + leucovorin + interferon in advanced colorectal cancer, 11, 548 van Hazel, 1992, Phase II study of the combination of 5fluorouracil, folinic acid and alpha-interferon in metastatic colorectal adenocarcinoma cancer, 11, 594 Pavesi, 1992, Modulation of 5fluorouracil with folinic acid plus beta interferon in metastatic colorectal cancer, Ann Oncol, 3, 63 Dalri, 1992, Double biochemical modulation of 5fluorouracil with leucovorin and interferon 2-a in advanced colorectal adenocarcinoma, Ann Oncol, 3 Dirix, 1992, Double modulation of 5fluorouracil with low dose leucovorin and alpha interferon in advanced colorectal carcinoma: a pilot study, Ann Oncol, 3 Sinnige, 1993, Update of a phase II study of 5-fluorouracil (5FU), leucovorin (LV) and alpha 2a interferon (IF) in advanced colorectal cancer, 12, 616 Labianca, 1992, High dose alpha-2b interferon + folinic acid in the modulation of 5fluorouracil. A phase II study in advanced colorectal cancer with evidence of an unfavorable cost/benefit ratio, Tumori, 78, 32, 10.1177/030089169207800107 Schuller, 1992, Influence of interferon alfa-2b with or without folinic acid on pharmacokinetics of fluorouracil, Semin Oncol, 19, 93